Diabetes Mellitus, Type 1 Clinical Trials in Orlando, Florida

4 studies are recruiting for diabetes mellitus, type 1 in Orlando, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

    The investigators will test the hypothesis that, in adults with type 1 diabetes (T1D), glucagon-like peptide-1 receptor agonism (GLP-1RA, i.e. dulaglutide) enhances insulin-mediated skeletal muscle microvascular perfusion via attenuating endothelial oxidative stress and thereby improving endothelia…

    Stage
    Phase 2
    Ages
    18 to 40
    Site
    AdventHealth Translational Research Institute, Orlando, Florida
    Run by
    AdventHealth Translational Research Institute

    See if you can join NCT05478707 on ClinicalTrials.gov

  2. Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

    50 children/adolescents (ages 6 to <18yrs) with T1D in suboptimal control (HbA1c≥8.0%) and lower SES (below 200% poverty line) on insulin therapy (either injections or open-loop pumps) will be recruited at Nemours ~ 1/3 each AA, Hispanic/Latino, non-Hispanic whites. All families that qualify and ag…

    Stage
    Not phased
    Ages
    6 to 17
    Site
    Nemours Children's Health, Orlando, Florida
    Locations
    2 in total
    Run by
    Nemours Children's Clinic

    See if you can join NCT05849753 on ClinicalTrials.gov

  3. Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

    Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because …

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    AdventHealth, Orlando, Florida
    Locations
    19 in total
    Run by
    Alessandro Doria

    See if you can join NCT06217302 on ClinicalTrials.gov

  4. Closed Loop and Education for Hypoglycemia Awareness Restoration

    The purpose of the CLEAR study is to determine the effect on counterregulatory responses (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of hypoglycemia (IAH). IAH a…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    AdventHealth, Orlando, Florida
    Locations
    8 in total
    Run by
    Milton S. Hershey Medical Center

    See if you can join NCT06325202 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.